Translational Neurodegeneration
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 19.1 | Q1 | 98.5% | 4.992 | Q1 | 99.1% |
| 2024 | 15.2 | Q1 | 98.1% | 3.850 | Q1 | 98.5% |
| 2023 | 10.8 | Q1 | 96.0% | 3.371 | Q1 | 98.3% |
| 2022 | 12.6 | Q1 | 96.0% | 2.571 | Q1 | 97.3% |
| 2021 | 9.9 | Q1 | 94.4% | 1.849 | Q1 | 95.3% |
| 2020 | — | — | 2.565 | Q1 | 97.1% | |
| 2019 | — | — | 1.812 | Q1 | 94.8% | |
| 2018 | — | — | 2.346 | Q1 | 96.3% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
2047-9158
country
GBcoverage
2012-2026